Baxter Healthcare Corporation

Form 483 issued March 3, 2017 · Irvine, California

Inspection
Feb 21 – Mar 3, 2017
Observations
4
Pages
4
FEI number
2025695

In short: On March 3, 2017, FDA issued a Form 483 with 4 observations to Baxter Healthcare Corporation in Irvine, California (FEI 2025695) after an inspection that ran Feb 21 – Mar 3, 2017. The investigators were Charles L. Larson and Sean T. Creighton. Most observations concern cAPA and production & process controls.

At a glance

CAPA and production & process controls account for 3 of 4 observations.

CAPA2
Production & process controls1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Process validation activities have…

  2. 02

    Corrective and preventive action activities and/or results have…

  3. 03

    Procedures have not been adequately established to control product that does not conform…

  4. 04

    : Not…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Baxter Healthcare Corporation?

FDA listed 4 observations on this Form 483, mostly about cAPA and production & process controls. The opening words of each observation are shown on this page.

Who inspected Baxter Healthcare Corporation?

Charles L. Larson and Sean T. Creighton are named on this Form 483, for the inspection of Feb 21 – Mar 3, 2017. Each investigator has a profile showing what they cite most.

When was Baxter Healthcare Corporation inspected by FDA?

The inspection ran Feb 21 – Mar 3, 2017, and the Form 483 is dated March 3, 2017.

How do I get the full Form 483 for Baxter Healthcare Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free